December 14, 2025
Headlines

GSK’s Blood Cancer Drug Review Extended As FDA Seeks More Data

Sumain Faisal01 mins

FDA extends Blenrep combo review to October to assess more data from Phase 3 trials in relapsed or refractory multiple myeloma.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News